Till startsida
University of Gothenburg
Sitemap
To content Read more abput how we use cookies on gu.se

4th Swedish Cancer Research Meeting November 7-8, 2016

Wallenberg Conference Centre, Gothenburg

                          UPDATED PROGRAM 

 

MONDAY NOVEMBER 7

08:30-10:20 Registration and coffee

10:20–10:30 Welcome address: Göran Stenman

PLENARY 1: TRANSLATIONAL AND CLINICAL ONCOLOGY

Chair: Jonas Bergh

10.30-11:15  KEYNOTE Richard Gray, University of Oxford
Strategic considerations and optimal research designs

11:15-11:35 Henrik Grönberg
The future diagnostic pipeline of prostate cancer: Including the Stockholm 3 model, imaging and genomics
11.35-11.55 Anna Martling
ALASCCA- an RCT in colorectal cancer treatment using a new biomarker and an old drug
11.55.12.15 Kaisa Fritzell
SCREESCO: Screening of Swedish Colons, a national study of colorectal cancer screening and possibly an implementation of screening in Sweden

12:15–13:15 Lunch

PLENARY 2: MOUSE MODELS OF CANCER

Chair: Jonas A. Nilsson and Marie Arsenian Henriksson

13:15-14:00 KEYNOTE Cathrin Brisken, EPFL, Lausanne
Estrogen receptor positive breast cancer: how the microenvironment matters

14:00-14:20 Rune Toftgård
Untangling the roles of tissue stem cells and developmental signaling pathways in cancer
14:20-14:40 Kristian Pietras
Microenvironmental control of malignant phenotypes
14:40-15:00 Martin Bergö
Consequences of targeting redox regulation in lung and skin tumors

15:00-16:00 Coffee & Poster Session 1

16:00-17:30 Parallell workshops

Genomics and genome editing
Drug discovery               
Cancer biomarkers
16:00-16:30
Anna Andersson
Activating mutations are potent pro-leukemic mediators in murine MLL-MLLT3 leukemia
16:00-16:30
Sonia Lain
Striving for precision in chemical biology
16:00-16:30
Karin Sundfeldt
The diagnostic potential of liquid biopsies in cancer
16:30-16:45
Jenna Persson
CRISPR/Cas9 screening: novel services provided by Karolinska High Throughput Center
16:30-16:45
Ruth Palmer
The ALK inhibitor PF-06463922 is effective as a single agent in neuroblastoma driven by expression of ALK and MYCN
16:30-16:45
Karolina S. Jabbar
Targeted proteomic analysis enables early identification of cystic forms and precursors of pancreatic cancer
16:45-17:00
Noemie Braekeveldt
Evolution of neuroblastoma patient-derived orthotopic xenografts through space and time
16:45-17:00
Mia Eriksson
TLR1/TLR2 activation forces acute myeloid leukemia cells into differentiation and apoptosis
16:45-17:00
Elin Thysell
Identification of biomarkers and therapeutic targets for aggressive prostate cancer by omics-based approaches
17:00-17:15
Nick Tobin
Multi-level gene expression signatures provide significant prognostic information in metastatic breast cancer patients
17:00-17:15
Jiyu Guan
Stromal cells contribute to ibrutinib resistance in Mantle cell lymphoma
17:00-17:15
Filip Mundt
Identifying and overcoming resistance mechanisms of PI3K inhibition
17:15-17:30
Kerryn Elliott
Recurrent promoter mutations in melanoma are defined by an extended context-specific mutational signature
17:15-17:30
Cecilia Krona
In vivo modeling of high grade glioma for oncology drug development
17:15-17:30
Su Chul Jang
Mitochondrial protein-containing extracellular vesicles and their diagnostic potential for cancer

17:30-19:00 Drinks & Poster Session 1
Music: Gunnar Steineck and Alexander Lövmark

19:00 Dinner at Restaurant Norden (2nd floor of the Wallenberg Conference Centre)


TUESDAY NOVEMBER 8

PLENARY 3: LUNG AND PANCREATIC CANCER

Chair: Peter Naredi and Lisa Rydén

08:30-09:15 KEYNOTE Fred Hirsch, University of Colorado
Current role of immunotherapy in NSCLC

09:15-09:35 Johan Botling
Lung cancer - diagnostics and research for targeted therapy in Sweden
09:35-09:55 Claus Jörgensen
Oncogenic KRAS regulates tumour cell function via stromal reciprocation 09:55-10:15 Carl Borrebaeck
Early detection of pancreatic ductal adenocarcinoma (PDAC)

10:15-10:35 Malin Sund
Early detection of pancreatic cancer

10:35-11:00 Coffee

11:00-12:30 Parallell workshops

Tumor cell nichesImmunotherapy
Epigenetics and systems biology
11:00-11:30
Hong Qian
Characterization of the leukemic bone marrow niche - a path to identify novel therapeutic targets
11:00-11:30
Magnus Essand
Immunotherapy of cancer using engineered viruses and T cells
11:00-11:30
Jussi Taipale
Dissection of transcriptional control of cancer cell growth using CRISPR/Cas9
11:30-12:00
Chris Madsen
Decellularising cancer – new insight into the tumour niche and its vasculature
11:30-11:45
Roni Allaoui
Cancer associated fibroblast-secreted CXCL16 attracts monocytes to promote stroma activation in triple negative breast cancers
11:30-11:45
David Gisselsson Nord
Trajectories of cancer cell evolution: a field map of clonal dynamic over space and time in peadiatric tumours
12:00-12:15
Lars Holmgren
Mechanical forces control morphogenesis and cancer
11:45-12:00
Erika Fletcher
T cell responses to peptide-epitopes of choice can be boosted by immune complexes of circulating anti-tetanus toxoid antibodies
11:45-12:00
Arghavan Ashouri
Pan-cancer transcriptomic analysis associates long non-coding RNAs with key mutational driver events
12:15-12:30
Elisa Stellaria Grassi
DLK1 is a promising candidate regulator of astrocyte and stem-like cancer cells interactions in GBM
12:00-12:15
Fredrik Bergh-Thorén
Impact of KIR/HLA mismatched NK cells on the efficacy of immunotherapy in acute myeloid leukemia
12:00-12:15
Patrik Johansson
Systems scale analysis and prospective modeling of patient-derived cells: a new responder subtype of glioblastoma
 12:15-12:30
Pablo Peña-Martínez
Interleukin 4 forces acute myeloid leukemia cells into apoptosis in a Stat6 dependent manner
12:15-12:30
Diogo Ribeiro
Regulation of nuclear hormone receptors by MYCN-driven miRNAs impacts neural differentiation and survival in neuroblastoma patients

12:30–13:30 Lunch

13:30-14:30 Poster Session 2

PLENARY 4: PRECISION CANCER MEDICINE

Chair: Ruth Palmer and Tobias Sjöblom

14:30-15:15  KEYNOTE Olli Kallioniemi, KI/SciLifeLab
Individualized systems medicine for tailoring the treatment of cancer patients

15:15-15:35 Jonas Nilsson
Patient-derived melanoma xenografts as tools in precision cancer medicine
15:35-15:55 Beatrice Melin
Etiological pathways of glioma - precision diagnostics of subgroups
15:55-16:15 Göran Landberg
The cancer microenvironment modulates tumour progressing properties in breast cancer

16:15-16:30 Poster Awards and concluding remarks
 

 

Page Manager: Veronica Norell|Last update: 11/3/2016
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?